SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.16 Cr | ₹0.37 Cr | ₹0.06 Cr | ₹-0.05 Cr | ₹-0.22 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SAKAR HEALTHCARE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-0.16 Cr |
| Mar2024 | ₹0.37 Cr |
| Mar2023 | ₹0.06 Cr |
| Mar2022 | ₹-0.05 Cr |
| Mar2021 | ₹-0.22 Cr |
How is Net Cash Inflow / Outflow of SAKAR HEALTHCARE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.16 Cr | Negative | |
| Mar2024 | ₹0.37 Cr | 481.25 | |
| Mar2023 | ₹0.06 Cr | Positive | |
| Mar2022 | ₹-0.05 Cr | Negative | |
| Mar2021 | ₹-0.22 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,007.9 Cr | 13% | 9.8% | 150.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 13% |
9.8% |
150.7% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses